ArticleMolecular therapy : the journal of the American Society of Gene Therapy2015

Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer.

Minal Barve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.